ID: ALA2115091

Max Phase: Preclinical

Molecular Formula: C28H26Cl2FNO5

Molecular Weight: 546.42

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  C[C@H](NC(=O)C[C@H](CC(=O)O)C(=O)O)[C@@H](Cc1ccc(Cl)c(Cl)c1)c1ccc(-c2ccccc2)c(F)c1

Standard InChI:  InChI=1S/C28H26Cl2FNO5/c1-16(32-26(33)14-20(28(36)37)15-27(34)35)22(11-17-7-10-23(29)24(30)12-17)19-8-9-21(25(31)13-19)18-5-3-2-4-6-18/h2-10,12-13,16,20,22H,11,14-15H2,1H3,(H,32,33)(H,34,35)(H,36,37)/t16-,20+,22+/m0/s1

Standard InChI Key:  NBRLADMQSZWKGO-SAWYMBPVSA-N

Associated Targets(Human)

Squalene synthetase 333 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 546.42Molecular Weight (Monoisotopic): 545.1172AlogP: 6.20#Rotatable Bonds: 11
Polar Surface Area: 103.70Molecular Species: ACIDHBA: 3HBD: 3
#RO5 Violations: 2HBA (Lipinski): 6HBD (Lipinski): 3#RO5 Violations (Lipinski): 2
CX Acidic pKa: 3.85CX Basic pKa: CX LogP: 6.06CX LogD: 0.84
Aromatic Rings: 3Heavy Atoms: 37QED Weighted: 0.27Np Likeness Score: -0.43

References

1. Iwasawa Y, Hayashi M, Nomoto T, Shibata J, Mitsuya M, Hirota K, Yonemoto M, Kamei T, Miura K, Tomimoto K.  (1995)  Synthesis and biological activity of J-104,118, a novel, potent inhibitor of squalene synthase,  (17): [10.1016/0960-894X(95)00339-U]

Source